Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A method for evaluating the level of soluble ß-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to ß-amyloid peptides.

A method for evaluating the level of soluble ß-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to ß-amyloid peptides. Angew Chem Int Ed Engl. 2014 Nov 17; 53(47):12832-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.